Cytosorbents Corporation
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -879.5% | -217.2% | -121.3% |
| FY2017 | -82.4% | -52.1% | -35.1% |
| FY2018 | -101.6% | -65.7% | -50.3% |
| FY2019 | -563.6% | -114.7% | -70.4% |
| FY2020 | -9.9% | -9.9% | -8.7% |
| FY2021 | -39.2% | -39.2% | -27.4% |
| FY2022 | -92.8% | -81.3% | -51.9% |
| FY2023 | -124.6% | -112.4% | -55.2% |
| FY2024 | -186.5% | -82.5% | -43.7% |
| FY2025 | -138.9% | -36.3% | -18.6% |